Sg Americas Securities, LLC Viking Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$17.2 Billion
Q2 2024

A detailed history of Sg Americas Securities, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 89,619 shares of VKTX stock, worth $4.85 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

89,619

Previous 25,540 250.9%

Holding current value

$4.85 Million

Previous $2.09 Million 126.89%

% of portfolio

0.03%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	BUY	$47.39 - $80.2 $3.04 Million - $5.14 Million	64,079 Added 250.9%	89,619 $4.75 Million
Q1 2024 May 06, 2024	SELL	$17.4 - $94.5 $103,582 - $562,558	-5,953 Reduced 18.9%	25,540 $2.09 Million
Q4 2023 Jan 12, 2024	SELL	$9.24 - $19.64 $467,599 - $993,901	-50,606 Reduced 61.64%	31,493 $586,000
Q3 2023 Oct 13, 2023	BUY	$10.92 - $16.0 $809,008 - $1.19 Million	74,085 Added 924.44%	82,099 $909,000
Q2 2023 Jul 10, 2023	BUY	$14.84 - $24.79 $118,927 - $198,667	8,014 New	8,014 $130,000
Q4 2022 Feb 02, 2023	BUY	$2.72 - $9.4 $29,060 - $100,429	10,684 New	10,684 $100,000
Q2 2022 Jul 29, 2022	SELL	$2.11 - $3.15 $166,373 - $248,377	-78,850 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$3.0 - $4.88 $38,841 - $63,181	-12,947 Reduced 14.1%	78,850 $237,000
Q4 2021 Feb 07, 2022	SELL	$4.6 - $6.72 $28,575 - $41,744	-6,212 Reduced 6.34%	91,797 $422,000
Q3 2021 Nov 01, 2021	BUY	$5.58 - $7.04 $479,221 - $604,609	85,882 Added 708.19%	98,009 $615,000
Q2 2021 Aug 12, 2021	BUY	$5.19 - $6.73 $62,939 - $81,614	12,127 New	12,127 $73,000
Q1 2021 May 13, 2021	SELL	$5.74 - $9.67 $723,848 - $1.22 Million	-126,106 Closed	0 $0
Q4 2020 Feb 04, 2021	SELL	$5.3 - $6.71 $938,746 - $1.19 Million	-177,122 Reduced 58.41%	126,106 $710,000
Q3 2020 Nov 09, 2020	BUY	$5.73 - $8.11 $1.34 Million - $1.9 Million	234,288 Added 339.84%	303,228 $1.77 Million
Q2 2020 Jul 20, 2020	SELL	$4.35 - $8.08 $455,845 - $846,719	-104,792 Reduced 60.32%	68,940 $497,000
Q1 2020 Apr 30, 2020	BUY	$3.45 - $7.95 $392,492 - $904,439	113,766 Added 189.72%	173,732 $813,000
Q4 2019 Jan 28, 2020	SELL	$6.38 - $8.73 $1.22 Million - $1.67 Million	-190,918 Reduced 76.1%	59,966 $481,000
Q3 2019 Nov 04, 2019	BUY	$6.55 - $8.6 $1.47 Million - $1.93 Million	224,456 Added 849.31%	250,884 $1.73 Million
Q2 2019 Jul 29, 2019	BUY	$7.67 - $10.63 $202,702 - $280,929	26,428 New	26,428 $219,000
Q1 2019 Apr 29, 2019	SELL	$7.58 - $9.94 $122,955 - $161,236	-16,221 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$7.16 - $16.21 $99,910 - $226,194	-13,954 Reduced 46.24%	16,221 $124,000
Q3 2018 Nov 06, 2018	BUY	$9.7 - $19.65 $292,697 - $592,938	30,175 New	30,175 $526,000

Others Institutions Holding VKTX

# of Institutions

442

Shares Held

63.3M

Call Options Held

6.23M

Put Options Held

2.97M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $4.15B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Viking Therapeutics, Inc. Transaction History